• Ann Tucker

New Study Examines Barriers to Buprenorphine Access in Pharmacies

A study recently published in Drug and Alcohol Dependence examined barriers encountered by patients seeking to fill buprenorphine prescriptions from pharmacies in counties with high opioid-related mortality rates. Researchers conducted a telephone audit and analyzed availability across pharmacy type and county characteristics. Results of the study indicated that 73% of pharmacies contacted reported being able to dispense buprenorphine and 20% reported they would not distribute the medication. In addition, independent pharmacies and pharmacies in southern States were significantly more likely to restrict buprenorphine. Read more

3 views0 comments

Recent Posts

See All

SAMHSA (11/10) –– The Substance Abuse and Mental Health Services Administration is pleased to announce the release of the agency’s Interim Strategic Plan (ISP), which presents a new mission and vision

The White House budget office is reviewing a draft SAMHSA rule that would make permanent the COVID-19 methadone take-home waiver and define which patients with OUD are considered “stable” enough to re